Researcher
Hans Prenen
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention, Cancer therapy
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Hans Prenen (KU Leuven)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Oct 2020 → Today - Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From12 Jul 2017 → 30 Apr 2018 - Clinical Digestive Oncology (Division)
Member
From1 Jan 2012 → 23 Jul 2017 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2009 → 31 Dec 2011
Projects
1 - 2 of 2
- Development of an image-based multiparametric drug response signature to predict clinical therapy response in cancer patients from ex vivo tumoroid screenings.From1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- Reinvigorating the antitumor immunity in human breastand cervical cancer with an innovative RANK(L) targeted combination strategy.From1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
Publications
71 - 80 of 151
- RANK-RANKL signaling in cancer of the uterine cervix(2019)
Authors: Peter Van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma, Filip Lardon, Tim Van den Wyngaert, Evelien Smits, Cecile Colpaert, Hans Prenen, et al.
- Ramucirumab(2019)
Authors: Celine Debeuckelaere, Sabina Murgioni, Sara Lonardi, Noemi Girardi, Giulia Alberti, Carolina Fano, Sara Gallimberti, Cristina Magro, Selma Ahcene-Djaballah, Francesca Daniel, et al.
Pages: 399 - 409 - Safety and tolerability of anti-angiogenic protein kinase inhibitors and vascular-disrupting agents in cancer(2019)
Authors: Letizia Procaccio, Vera Damuzzo, Francesca Di Sarra, Alberto Russi, Federica Todino, Vincenzo Dadduzio, Francesca Bergamo, Alessandra Anna Prete, Sara Lonardi, Hans Prenen, et al.
Pages: 159 - 179 - Highlights in digestive oncology(2019)
Authors: K. Papadimitriou, Marc Peeters, Hans Prenen
Pages: 346 - 350 - Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases(2019)
Authors: RC Dresen, Sofie De Vuysere, Frederik De Keyzer, Eric Van Cutsem, Hans Prenen, Ragna Vanslembrouck, Gert De Hertogh, Albert Wolthuis, André D’Hoore, Vincent Vandecaveye
Pages: 1 - 10 - Chimeric antigen receptor-T cells for targeting solid tumors(2019)
Authors: Lorraine Springuel, Caroline Lonez, Bertrand Alexandre, Eric Van Cutsem, Jean-Pascal H. Machiels, Marc Van Den Eynde, Hans Prenen, Alain Hendlisz, Leila Shaza, Javier Carrasco, et al.
Pages: 515 - 537 - Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy(2019)
Authors: Lieven Depypere, Melissa Thomas, Johnny Moons, Willy Coosemans, Toni Lerut, Hans Prenen, Karin Haustermans, Hans Van Veer, Philippe Nafteux
- RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment(2019)
Authors: Peter Van Dam, Yannick Verhoeven, Xuan Bich Trinh, An Wouters, Filip Lardon, Hans Prenen, Evelien Smits, Marcella Baldewijns, Martin Lammens
Pages: 85 - 91 - Should anti-EGFR agents be used in right-sided RAS wild-type advanced colorectal cancer?(2019)
Authors: Lars Triest, C. Debeuckelaere, Timon Vandamme, B. Van Den Heuvel, Jan van den Brande, K. Papadimitriou, M. Rasschaert, Hans Prenen, Marc Peeters
Pages: 130 - 134 - Survival outcomes in patients with RAS wild type metastatic colorectal cancer classified according to Kohne prognostic category and BRAF mutation status(2018)
Authors: Salvatore Siena, Fernando Rivera, Julien Taieb, Marc Peeters, Hans Prenen, Reija Koukakis, Gaston Demonty, Claus-Henning Kohne
Pages: 50 - 57